Annual Operating Expenses
$5.22 M
-$290.30 K-5.27%
December 31, 2023
Summary
- As of February 24, 2025, CTCX annual total operating expenses is $5.22 million, with the most recent change of -$290.30 thousand (-5.27%) on December 31, 2023.
- During the last 3 years, CTCX annual operating expenses has risen by +$3.28 million (+168.89%).
- CTCX annual operating expenses is now -5.27% below its all-time high of $5.51 million, reached on December 31, 2022.
Performance
CTCX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$1.44 M
+$232.00 K+19.28%
September 30, 2024
Summary
- As of February 24, 2025, CTCX quarterly total operating expenses is $1.44 million, with the most recent change of +$232.00 thousand (+19.28%) on September 30, 2024.
- Over the past year, CTCX quarterly operating expenses has stayed the same.
- CTCX quarterly operating expenses is now -48.51% below its all-time high of $2.79 million, reached on December 31, 2022.
Performance
CTCX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
CTCX Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.3% | 0.0% |
| 3 y3 years | +168.9% | -48.5% |
| 5 y5 years | +168.9% | -48.5% |
CTCX Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -5.3% | +168.9% | -48.5% | +402.1% |
| 5 y | 5-year | -5.3% | +168.9% | -48.5% | +402.1% |
| alltime | all time | -5.3% | +168.9% | -48.5% | +402.1% |
Carmell Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.44 M(+19.3%) |
| Jun 2024 | - | $1.20 M(-12.8%) |
| Mar 2024 | - | $1.38 M(+314.5%) |
| Dec 2023 | $5.22 M | $333.00 K(-84.3%) |
| Sep 2023 | - | $2.12 M(+42.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $1.49 M(+16.7%) |
| Mar 2023 | - | $1.27 M(-54.3%) |
| Dec 2022 | $5.51 M(+183.9%) | $2.79 M(+227.3%) |
| Sep 2022 | - | $851.90 K(+198.0%) |
| Jun 2022 | - | $285.90 K |
| Dec 2021 | $1.94 M | - |
FAQ
- What is Carmell Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Carmell Therapeutics?
- What is Carmell Therapeutics annual operating expenses year-on-year change?
- What is Carmell Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Carmell Therapeutics?
- What is Carmell Therapeutics quarterly operating expenses year-on-year change?
What is Carmell Therapeutics annual total operating expenses?
The current annual operating expenses of CTCX is $5.22 M
What is the all time high annual operating expenses for Carmell Therapeutics?
Carmell Therapeutics all-time high annual total operating expenses is $5.51 M
What is Carmell Therapeutics annual operating expenses year-on-year change?
Over the past year, CTCX annual total operating expenses has changed by -$290.30 K (-5.27%)
What is Carmell Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of CTCX is $1.44 M
What is the all time high quarterly operating expenses for Carmell Therapeutics?
Carmell Therapeutics all-time high quarterly total operating expenses is $2.79 M
What is Carmell Therapeutics quarterly operating expenses year-on-year change?
Over the past year, CTCX quarterly total operating expenses has changed by $0.00 (0.00%)